Reference: Umapathysivam MM, Araldi E, Hastoy B, et al
The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): a randomized controlled trial
Orforglipron doesnt do this
While these cardiovascular benefits may be related to multiple mechanisms, including weight loss, the specific contribution of visceral fat reduction has not been definitively established
It is studied for its body protection, tissue repair, and cytoprotection properties, with research focusing on its ability to support and repair bodily tissues, maintain vascular integrity, and promote healing
Abstract Valproic acid (VPA) is widely used as a major drug in the treatment of epilepsy